Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains

FEBS Journal

Volumn 280, Issue 10, 2013, Pages 2320-2331

  Manon Jensen, Tina ^a   Multhaupt, Hinke A B ^a   Couchman, John R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

metzincin; proteinase; proteoglycan; receptor; shedding

Indexed keywords

GELATINASE A; GELATINASE B; HEPARAN SULFATE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; PLASMIN; STROMELYSIN; SYNDECAN 1; SYNDECAN 4; THROMBIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; CELL MEMBRANE; CONSERVED SEQUENCE; ENZYME ACTIVATION; ENZYME ASSAYS; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SOLUBILITY; SYNDECAN-1; SYNDECAN-4;

EID: 84877721994     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12174     Document Type: Article

References (49)

1. Lambaerts K, Wilcox-Adelman SA, &, Zimmermann P, (2009) The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin Cell Biol 5, 662-669.
2. Bass MD, Morgan MR, &, Humphries MJ, (2009) Syndecans shed their reputation as inert molecules. Sci Signal 2, pe18.
3. Couchman JR, (2010) Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol 10, 89-114.
4. Deepa SS, Yamada S, Zako M, Goldberger O, &, Sugahara K, (2004) Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J Biol Chem 279, 37368-37376. (Pubitemid 39195445)
5. Bartlett AH, Havashida K, &, Park PW, (2007) Molecular and cellular mechanisms of syndecans in tissue injury and inflammation. Mol Cells 24, 153-166. (Pubitemid 350177174)
6. Okina E, Manon-Jensen T, Whiteford JR, &, Couchman JR, (2009) Syndecan proteoglycan contributions to cytoskeletal organization and contractility. Scand J Med Sci Sports 19, 479-489.
7. Xian X, Gopal S, &, Couchman JR, (2010) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 339, 31-46.
8. Choi Y, Chung H, Jung H, Couchman JR, &, Oh ES, (2011) Syndecans as cell surface receptors: unique structure equates with functional diversity. Matrix Biol 30, 93-99.
9. Manon-Jensen T, Itoh Y, &, Couchman JR, (2010) Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J 277, 3876-3889.
10. Kim CW, Goldberger OA, Gallo RL, &, Bernfield M, (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell 5, 797-805. (Pubitemid 24254349)
11. Li Q, Park PW, Wilson CL, &, Parks WC, (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111, 635-646. (Pubitemid 35441246)
12. Fux L, Ilan N, Sanderson RD, &, Vlodavsky I, (2009) Heparanase: busy at the cell surface. Trends Biochem Sci 34, 511-519.
13. Lamanna WC, Frese MA, Balleininger M, &, Dierks T, (2008) Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem 283, 27724-27735.
14. Bishop JR, Schuksz M, &, Esko JD, (2007) Heparan sulphate proteoglycans fine tune mammalian physiology. Nature 446, 1030-1037. (Pubitemid 46676065)
15. Brule S, Charnaux N, Sutton A, Ledoux D, Chaigneau T, Saffar L, &, Gattegno L, (2006) The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology, 16, 488-501. (Pubitemid 43779045)
16. Fears CY, Gladson CL, &, Woods A, (2006) Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J Biol Chem 281, 14533-14536. (Pubitemid 43855155)
17. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, &, Sato H, (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278, 40764-40770. (Pubitemid 37280893)
18. Wang Z, Götte M, Bernfield M, &, Reizes O, (2005) Constitutive and accelerated shedding of murine syndecan-1 is mediated by cleavage of its core protein at a specific juxtamembrane site. Biochemistry 44, 12355-12361. (Pubitemid 41324327)
19. Theocharis AD, Skandelis SS, Tzanakakis GN, &, Karamanos NK, (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277, 3904-3923.
20. Afratis N, Gialeli C, Nikitovic D, Tseganidis AD, Karousou E, Pavão MS, Tzanakakis GN, &, Karamanos NK, (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279, 1177-1197.
21. Schmidt A, Echtermeyer F, Alozie A, Brands K, &, Buddecke E, (2005) Plasmin- and thrombin-accelerated shedding of syndecan-4 ectodomain generates cleavage sites at Lys(114)-Arg(115) and Lys(129)-Val(130) bonds. J Biol Chem 280, 34441-34446. (Pubitemid 41504572)
22. Munesue S, Yoshitomi Y, Kusano Y, Koyama Y, Nishiyama A, Nakanishi H, Miyazaki K, Ishimaru T, Miyaura S, Okayama M, et al,. (2007) A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem 282, 28164-28174. (Pubitemid 47529519)
23. Yu WH, &, Woessner JF, (2001) Heparin-enhanced zymographic detection of matrilysin and collagenases. Anal Biochem 293, 38-42.
24. Nam EJ, &, Park PW, (2012) Shedding of cell membrane-bound proteoglycans. Methods Mol Biol 836, 291-305.
25. Subramanian SV, Fitzgerald ML, &, Bernfield M, (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272, 14713-14720. (Pubitemid 27251736)
26. Joensuu H, Anttonen A, Eriksson M, Mäkitaro R, Alfthan H, Kinnula V, &, Leppä S, (2002) Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer. Cancer Res 62, 5210-5217. (Pubitemid 35024592)
27. Vassilakopoulos TP, Kyrtsonis MC, Papadogiannis A, Nadali G, Angelopoulou MK, Tzenou T, Dimopoulou MN, Siakantaris MP, Kontopidou FN, Kalpadakis C, et al,. (2005) Serum levels of soluble syndecan-1 in Hodgkin's lymphoma. Anticancer Res 25, 4743-4746. (Pubitemid 41729540)
28. Seidel C, Sundan A, Hjorth M, Turesson I, Dahl IM, Abildgaard N, Waage A, &, Borset M, (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood 95, 388-392. (Pubitemid 30041645)
29. Dhodapkar MV, Kelly T, Theus A, Athota AB, Barlogie B, &, Sanderson RD, (1997) Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma. Br J Haematol 99, 368-371. (Pubitemid 27497569)
30. Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, Epstein J, &, Sanderson RD, (2002) Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100, 610-617. (Pubitemid 34761126)
31. Khotskaya YB, Dai Y, Ritchie JP, MacLeod V, Yang Y, Zinn K, &, Sanderson RD, (2009) Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo. J Biol Chem 284, 26085-26095.
32. Purushothaman A, Uvama T, Kobayashi F, Yamada S, Sugahara K, Rapraeger AC, &, Sanderson RD, (2010) Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115, 2449-2457.
33. Pechik I, Nachman J, Ingham K, &, Gilliland GL, (1993) Crystallization and preliminary X-ray diffraction data of two heparin-binding fragments of human fibronectin. Proteins 16, 43-47. (Pubitemid 23129871)
34. Sharma A, Askari JA, Humphries MJ, Jones EY, &, Stuart DI, (1999) Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J 18, 1468-1479. (Pubitemid 29127061)
35. Gao G, Plaas A, Thompson VP, Jin S, Zuo F, &, Sandy JD, (2004) ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem 279, 10042-10051. (Pubitemid 38372607)
36. Echtermeyer F, Bertrand J, Dreier R, Meinecke I, Neugebauer K, Fuerst M, Lee YJ, Song YW, Herzog C, Theilmeier G, et al,. (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 15, 1072-1076.
37. Pruessmeyer J, Martin C, Hess FM, Schwarz N, Schmidt S, Kogel T, Hoettecke N, Schmidt B, Sechi A, Uhlig S, et al,. (2010) A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells. J Biol Chem 285, 555-564.
38. Whiteford JR, &, Couchman JR, (2006) A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain. J Biol Chem 281, 32156-32163. (Pubitemid 46036770)
39. Beauvais DM, Ell BJ, McWhorter AR, &, Rapraeger AC, (2009) Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med 206, 691-705.
40. Beauvais DM, Burbach BJ, &, Rapraeger AC, (2004) The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol 167, 171-181. (Pubitemid 39363424)
41. McQuade KJ, Beauvais DM, Burbach BJ, &, Rapraeger AC, (2006) Syndecan-1 regulates alphavbeta5 integrin activity in B82L fibroblasts. J Cell Sci 119, 2445-2456. (Pubitemid 44070426)
42. Langford JK, Yang Y, Kieber-Emmons T, &, Sanderson RD, (2005) Identification of an invasion regulatory domain within the core protein of syndecan-1. J Biol Chem 280, 3467-3473. (Pubitemid 40223811)
43. Whiteford JR, Xian X, Chaussade C, Vanhaesebroeck B, Nourshargh S, &, Couchman JR, (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell 19, 3609-3624.
44. Levy-Adam F, Feld S, Suss-Toby E, Vlodavsky I, &, Ilan N, (2008) Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans. PLoS ONE 3, e2319.
45. Fillmore HL, VanMeter TE, &, Broaddus WC, (2001) Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neurooncol 53, 187-202. (Pubitemid 33034691)
46. Itoh Y, Ito N, Nagase H, Evans RD, Bird SA, &, Seiki M, (2006) Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP. Mol Biol Cell 17, 5390-5399. (Pubitemid 44907378)
47. Itoh Y, Palmisano R, Anilkumar N, Nagase H, Miyawaki A, &, Seiki M, (2011) Dimerization of MT1-MMP during cellular invasion detected by fluorescence resonance energy transfer. Biochem J 440, 319-326.
48. Okada Y, Nagase H, &, Harris EJ, (1986) A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue components. Purification and characterization. J Biol Chem 261, 14245-14255. (Pubitemid 17196334)
49. Nagase H, (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378, 151-160. (Pubitemid 27230597)